Starting from scratch: The primary hyperacidity theory of the cause of pyloric stenosis of infancy
Keywords:Etiology, Pyloric stenosis of infancy, Neonate, Hypergastrinemia, Hyperacidity, Gastrin
The early observations of those who first described babies with pyloric stenosis (PS) are used as a backdrop for the development of the Inherited Primary Hyperacidity theory of cause. Those early truths, uncomplicated by modern technology, have acted as a springboard for pathogenesis. Hyperacidity, male predominance, family history, self-cure, enhanced appetite, and time-sensitive presentation were all well known to the early pioneers. Any system of pathogenesis must explain all these clinical features. The Inherited Primary Hyperacidity theory does this and is a credible explanation for all the clinical features established by these early pioneers. The evidence which supports a delay in maturation of the negative feedback between gastrin and gastric acidity is presented. Such a phenomenon further supports the Primary Hyperacidity theory.
Mack HC. A history of hypertrophic pyloric stenosis and its treatment: Part 1 and 2. Bulletin History Med. 1942; 12:465-85.
Lenden AA. Congenital hypertrophic stenosis. Aus Med J. 1912; 6:417-9.
Carmichael DL. Infantile hypertrophy of the pylorus with spasm causing obstruction. D. L. Carmichael M.B., Ch.B. University of Glasgow 1911.
Rogers IM, Drainer IK, Dougal AJ. Serum cholecystokinin, basal acid secretion and infantile hypertrophic pyloric stenosis. Arch Dis Childhood. 1979; 54:773-5.
Heine W, Grager B, Litzenberger M, Drescher U. Results of Lambling gastric juice analysis (histamine stimulation) in infants with spastic hypertrophic pyloric stenosis. Pediatr Pathol. 1986; 21:119-25.
Fisher RS, Lipshutz W, Cohen S. The hormonal regulation of the pyloric sphincter function. J Clin Invest. 1973; 52:1289-96.
Crean GP, Hogg DF, Rumsey RDE. Hyperplasia of the gastric mucosa produced by duodenal obstruction. Gastroenterol. 1969; 56:193-9.
Dodge JA, Karim AA. Induction of pyloric hypertrophy by pentagastrin. Gut. 1976; 17:280-4.
Mary A. Gastric acidity in the first 10 days of life of the prematurely born baby. Amer J Dis Child. 1959; 2:1123-6.
Agunod M. Correlative study of hydrochloric acid, pepsin and intrinsic factor secretion in newborns and infants Am J Digest Dis. 1969; 14:400-13.
Ehrlein H, Shemann. Gastrointestinal motility. Available from:
Banieghbal. Personal communication. 2013.
Gerrard JW, Waterhouse JAH, Maurice DG. Infantile pyloric stenosis. Arch Dis Child. 1955; 30:493-6.
Dodge JA. ABO blood groups and IHPS. BMJ. 1967; 4:781-2.
Koster KH, Sindrup E, Seele V. ABO blood groups and gastric acidity. The Lancet. 1955; 9:52-6.
Rogers IM, Davidson DC, Lawrence J, Ardill J, Buchanan KD. Neonatal secretion of gastrin and glucagon. Arch Dis Child. 1974; 49;796-801.
Euler AR, Byrne WJ, Meisse PJ, Leake RD, Ament MF. Basal and pentagastrin stimulated acid secretion in new-born infants. Ped Res. 1979; 13:36-7.
Moazam F, Kirby WJ, Rodgers BM, McGuigan JE. Physiology of serum gastrin production in neonates and infants. Ann Surg. 1984; 199: 389-92.
Lucas A, Adrian TE, Christofides N, Bloom SR, Aynsley-Green A. Plasma motilin, gastrin and enteroglucagon and feeding in the human newborn. Arch Dis Child. 1980; 55:673-7.
Molloy MH, Morris FH, Denson SE, Weisbrodt NW, Lichtenberger LM, Adcock III EW. Neonatal gastric motility in dogs: maturation and response to pentagastrin. Am J Physiol. 1979; 236:E562-6.
Rogers IM. Pyloric stenosis of infancy and primary hyperacidity - the missing link. Acta Paediatr. 2014; Available from: https://doi.org/10.1111/apa.12795.
How to Cite
Copyright (c) 2022 Ian Munro Rogers
This work is licensed under a Creative Commons Attribution 4.0 International License.
You are free to:
- Share — copy and redistribute the material in any medium or format
- Adapt — remix, transform, and build upon the material for any purpose, even commercially.
- Attribution — You must give appropriate credit, provide a link to the license, and indicate if changes were made. You may do so in any reasonable manner, but not in any way that suggests the licensor endorses you or your use.
- No additional restrictions — You may not apply legal terms or technological measures that legally restrict others from doing anything the license permits.